LINC02003

Across TCGA pan-cancer cohorts, LINC02003 RNA differs between tumor and matched normal tissue in 13 of 18 cancer types tested, making tumor–normal expression one of LINC02003’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where LINC02003 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC02003 is over-expressed in tumor, although a few such as KICH show the opposite, repressed pattern.

LUAD, KICH, and LUSC are the cancer types where LINC02003 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02003 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	Female	II,III,IV	+0.382	<.001	8	view →
KICH	All	II,III,IV	−0.217	<.001	8	view →
LUSC	All	All	+0.225	<.001	6	view →
UCEC	All	II,III,IV	+0.216	.004	6	view →
KIRP	Male	All	+0.212	<.001	6	view →
THCA	All	All	+0.100	<.001	6	view →
KIRC	Male	All	+0.144	<.001	4	view →
HNSC	All	All	+0.060	.008	4	view →
BRCA	All	II,III,IV	+0.031	.019	4	view →
STAD	All	II,III,IV	+0.064	.013	3	view →
CHOL	All	All	+0.091	.034	1	view →
READ	All	All	+0.072	.034	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 13 lineages.

LINC02003–LUAD

Open the LUAD breakdown →